ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1825

Vascular Calcifications Adjacent to the Involved Joint of Patients Diagnosed with Calcium Pyrophosphate Crystal Arthritis – a Retrospective Observational Study

Shay Brikman1, Amir Bieber2 and Reuven Mader1, 1Rheumatic Diseases Unit, Emek Medical Center, Afula, Israel, 2Emek Medical Center, Raanana, Israel

Meeting: ACR Convergence 2022

Keywords: Cardiovascular, CPPD, Crystal-induced arthritis, pseudogout, X-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Prior studies have shown an association between chondrocalcinosis (CC) and vascular calcifications. In this study, we aimed to assess the presence of vascular calcifications adjacent to the involved joint seen on plain X-ray radiographs (XR) of patients diagnosed with calcium pyrophosphate (CPP) crystal arthritis.

Methods: A retrospective analysis was conducted assessing joint (knee, wrist) radiographs of patients with CPP crystal arthritis in an academic medical center from 2012 to 2022. All patients included were older than 60 years. Diagnosis of CPP crystal arthritis was considered if the patient had at least one previous acute synovitis with synovial fluid CPP crystals and/or CC and no other rheumatological inflammatory disease. A review of XR for vascular calcifications adjacent to the involved joint was performed by 2 independent observers. As control served a random sample of patients with osteoarthritis (OA) and no CC, matched for age and gender (1:1). The frequency of the presence of vascular calcifications adjacent to the involved joint was compared between the CPP and the control groups. Sensitivity, specificity, and positive likelihood ratio (LR) for CPP crystal arthritis based on the detection of XR vascular calcifications were calculated.

Results: 73 patients were included in the CPP crystal arthritis group and 73 patients in the control group. Vascular calcifications adjacent to the involved joint were seen in 52 patients in the CPP group and only in 13 patients in the control group (71.2% vs 17.8% respectively), which was significantly higher and suggests an association between CPP crystal arthritis and the presence of vascular calcifications on XR (Yates’ correction for X2=40.04, P< 0.0001). According to our analysis, the addition of the presence of vascular calcifications on XR to the investigation of inflamed joints in patients between the age of 60-85 with CC seen in the involved joint yielded a high specificity of 0.86 and a positive LR of 4.78.

Conclusion: Vascular calcifications seen on XR adjacent to the involved joint were detected at a significantly higher frequency in patients with CPP crystal arthritis than in patients with OA. Investigation of synovitis and CC in older patients should include the assessment of joint XR for the appearance of vascular calcifications as it may be regarded as an important radiologic sign for CPP crystal arthritis.

Supporting image 1

Knee X-ray radiograph of a patient diagnosed with calcium pyrophosphate crystal arthritis showing vascular calcifications

Supporting image 2

Wrist X-ray radiograph of a patient diagnosed with calcium pyrophosphate crystal arthritis showing vascular calcifications


Disclosures: S. Brikman, None; A. Bieber, None; R. Mader, AbbVie/Abbott, Pfizer, Eli Lilly, GlaxoSmithKlein(GSK), Protalix.

To cite this abstract in AMA style:

Brikman S, Bieber A, Mader R. Vascular Calcifications Adjacent to the Involved Joint of Patients Diagnosed with Calcium Pyrophosphate Crystal Arthritis – a Retrospective Observational Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/vascular-calcifications-adjacent-to-the-involved-joint-of-patients-diagnosed-with-calcium-pyrophosphate-crystal-arthritis-a-retrospective-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vascular-calcifications-adjacent-to-the-involved-joint-of-patients-diagnosed-with-calcium-pyrophosphate-crystal-arthritis-a-retrospective-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology